Clinical Trial Update: Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVT [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing bemiparin to enoxaparin for the treatment of deep vein thrombosis has completed, with an efficacy update provided from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis

Drugs mentioned

• Bemiparin (bemiparin)
• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Berlin-Chemie AG Menarini Group | Conditions: Deep Vein Thrombosis | Phase 3 | Status: COMPLETED